Comparative study on the cardioprotective effects against ischemia/reperfusion injury of the selective SGLT2 inhibitors, empagliflozin, dapagliflozin and ertugliflozin in non-diabetic mice
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Ischaemia, Infarction, Cardioprotection
Session:
Basic science e-posters